Aimei Health Technology (NASDAQ:AFJK) Trading 4.2% Higher – Should You Buy?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) shares shot up 4.2% on Monday . The stock traded as high as $50.00 and last traded at $50.50. 4,247 shares changed hands during mid-day trading, a decline of 79% from the average session volume of 19,772 shares. The stock had previously closed at $48.46.

Analyst Upgrades and Downgrades

AFJK has been the subject of several research analyst reports. Wall Street Zen upgraded Aimei Health Technology to a “sell” rating in a research note on Saturday, January 17th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Aimei Health Technology Stock Performance

The stock has a market capitalization of $309.06 million, a price-to-earnings ratio of 240.49 and a beta of -3.65. The firm has a fifty day moving average of $48.81 and a 200-day moving average of $24.58.

Aimei Health Technology (NASDAQ:AFJK) last issued its quarterly earnings data on Tuesday, November 18th. The company reported $0.06 EPS for the quarter.

Institutional Trading of Aimei Health Technology

Large investors have recently bought and sold shares of the company. Geode Capital Management LLC purchased a new stake in shares of Aimei Health Technology during the fourth quarter valued at approximately $413,000. Dakota Wealth Management purchased a new position in shares of Aimei Health Technology in the fourth quarter valued at $406,000. Quarry LP grew its holdings in Aimei Health Technology by 6.4% during the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Clear Street Group Inc. purchased a new stake in Aimei Health Technology during the 3rd quarter worth $691,000. Finally, Berkley W R Corp lifted its holdings in Aimei Health Technology by 5.9% in the 3rd quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock worth $5,101,000 after buying an additional 25,294 shares in the last quarter. Institutional investors and hedge funds own 45.58% of the company’s stock.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.